Comparable stake leader
Chan Heng Fai Ambrose
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0000771999.
Comparable stake leader
Chan Heng Fai Ambrose
Disclosed value leader
Chan Heng Fai Ambrose
Comparable rows
18/22
Latest evidence
31 Mar 2026
Ownership snapshot
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Quick read
18 of 22 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Chan Heng Fai Ambrose |
13D/G
3/4/5
Heng Fai Ambrose Chan · Director, 10%+ Owner
|
68%
|
$6,533,386
6,599,380 shares
|
-$129,372 | 28 Aug 2025 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
0.6%
|
$48,167
58,032 shares
|
— | 31 Mar 2026 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.56%
|
$45,119
54,351 shares
|
— | 31 Mar 2026 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.38%
|
$30,911
37,242 shares
|
— | 31 Mar 2026 |
| BlackRock, Inc. |
13F
Company
|
0.22%
|
$17,411
20,977 shares
|
— | 31 Mar 2026 |
| CITADEL ADVISORS LLC |
13F
Company
|
0.2%
|
$16,138
19,443 shares
|
— | 31 Mar 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
0.12%
|
$9,872
11,894 shares
|
— | 31 Mar 2026 |
| TWO SIGMA SECURITIES, LLC |
13F
Company
|
0.11%
|
$8,436
10,164 shares
|
— | 31 Mar 2026 |
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Net insider flow leans to buying over the last 12 months. Net value: +$176,090.
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 130,679 | 0 | $176,090 | $0 | +$176,090 |
Reporting owners
Showing 1-9 of 9 reporting-owner rows connected to DSS, INC.. Open a relationship link for the CIK-to-CIK filing trail.
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Alset International Ltd | 10%+ Owner | $3,615,449 | Mixed | 12 Jul 2022 | ||
| Alset Inc. | 10%+ Owner | $2,605,362 | Mixed | 08 Sep 2021 | ||
| Chan Heng Fai Ambrose | Director, 10%+ Owner | $1,419,990 | +$176,090 | +14% | Filing P/S | 28 Aug 2025 |
| Global BioMedical Pte. Ltd. | Former 10% Owner | $1,012,980 | Mixed | 08 Sep 2021 | ||
| Frank D. Heuszel | Chief Executive Officer, Director | $171,974 | Mixed | 10 Apr 2023 | ||
| Wu William Wai Leung | Director | Mixed | 29 Dec 2023 | |||
| Sheng Hon Danny Lim | Director | Mixed | 02 Oct 2023 | |||
| Wong Shui Yeung | Director | Mixed | 08 Jul 2022 | |||
| Joanne Wong Hiu Pan | Director | Mixed | 11 Jul 2022 |
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Heng Fai Ambrose Chan | DSS | Common Stock | Sale | 14.2% | $176,090 | $1.35 | 130,679 | 1,053,796 | 28 Aug 2025 | Direct |
| Heng Fai Ambrose Chan | DSS | Convertible Promissory Note | Other | 0 | $500,000 | 20 Aug 2025 | See footnote |